Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance

被引:36
作者
Jeong, Seogsong [1 ]
Kim, Kyuwoong [2 ]
Chang, Jooyoung [1 ]
Choi, Seulggie [1 ]
Kim, Sung Min [1 ]
Son, Joung Sik [3 ]
Lee, Gyeongsil [3 ]
Kim, Won [4 ]
Park, Sang Min [1 ,3 ]
机构
[1] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea
[2] Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, Gyeonggi Do, South Korea
[3] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea
[4] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Div Gastroenterol & Hepatol,Dept Internal Med, Seoul, South Korea
关键词
Nonalcoholic fatty liver disease (NAFLD); non-invasive diagnosis; metabolic risk factors; insulin resistance; ALCOHOLIC STEATOHEPATITIS; UNITED-STATES; HEPATOCELLULAR-CARCINOMA; DIAGNOSIS; EPIDEMIOLOGY; POPULATION; FIBROSIS; OBESITY; NEED;
D O I
10.21037/atm-20-2951
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Nonalcoholic fatty liver disease (NAFLD) is estimated to affect approximately 30% population worldwide. However, there is yet a basic and generally implementable approach to define individuals at risk for NAFLD estimative of metabolic risk. Methods: Total of 3,634 general participants without history of liver disease and alcohol consumption who received the Korean National Health and Nutrition Examination Survey between 2008 and 2010 were studied. Logistic regression was used to identify significant covariates indicative of NAFLD. Multivariable-adjusted logistic regression was carried out for evaluation on estimative impact of the derived score on metabolic risks. Results: Sex [female; odd ratio (OR), 2.492; 95% confidence interval (CI), 1.921-3.233; P<0.001], waist circumference (WC) (OR, 1.093; 95% CI, 1.077-1.110, P<0.001) systolic blood pressure (OR, 1.033; 95% CI, 1.025-1.040; P<0.001), fasting serum glucose ( FSG) (OR, 1.032; 95% CI, 1.026-1.038; P<0.001), triglyceride (OR, 1.007; 95% CI, 1.006-1.009; P<0.001), and alanine aminotransferase (OR, 1.110; 95% CI, 1.097-1.124; P<0.001) were independently indicative of NAFLD, which constituted the derived scoring system. The system revealed a significant correlation with the NAFLD liver fat score, fatty liver index (FLI), body mass index, age, alanine aminotransferase, and triglycerides (BAAT) score, lipid accumulation product, and hepatic steatosis index. In addition, the derived score was significantly estimative of insulin resistance. Conclusions: The developed score may be supportive of stratification of individuals at high risk of NAFLD, non-invasive fast diagnosis of NAFLD, and estimation of metabolic risk. Future studies that compare the derived score with standard diagnostic tests-validated data, such as ultrasonography of the liver, are needed.
引用
收藏
页数:12
相关论文
共 30 条
[1]   Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future [J].
Araujo, Ana Ruth ;
Rosso, Natalia ;
Bedogni, Giorgio ;
Tiribelli, Claudio ;
Bellentani, Stefano .
LIVER INTERNATIONAL, 2018, 38 :47-51
[2]   Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies [J].
Barba, C ;
Cavalli-Sforza, T ;
Cutter, J ;
Darnton-Hill, I ;
Deurenberg, P ;
Deurenberg-Yap, M ;
Gill, T ;
James, P ;
Ko, G ;
Miu, AH ;
Kosulwat, V ;
Kumanyika, S ;
Kurpad, A ;
Mascie-Taylor, N ;
Moon, HK ;
Nishida, C ;
Noor, MI ;
Reddy, KS ;
Rush, E ;
Schultz, JT ;
Seidell, J ;
Stevens, J ;
Swinburn, B ;
Tan, K ;
Weisell, R ;
Wu, ZS ;
Yajnik, CS ;
Yoshiike, N ;
Zimmet, P .
LANCET, 2004, 363 (9403) :157-163
[3]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[4]   Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential [J].
Bedossa, Pierre .
LIVER INTERNATIONAL, 2018, 38 :64-66
[5]   Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass [J].
Boza, C ;
Riquelme, A ;
Ibañez, L ;
Duarte, I ;
Norero, E ;
Viviani, P ;
Soza, A ;
Fernandez, JI ;
Raddatz, A ;
Guzman, S ;
Arrese, M .
OBESITY SURGERY, 2005, 15 (08) :1148-1153
[6]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[7]   Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know? [J].
Budd, Jeffrey ;
Cusi, Kenneth .
AMERICAN JOURNAL OF MEDICINE, 2020, 133 (05) :536-543
[8]   Correlation between serum 25-OH vitamin D expression and non-alcoholic fatty liver disease [J].
Cai, Jiayan ;
Zhang, Zhenyu ;
Liu, Jingqi ;
Xiao, Xueling ;
Wang, Chizhen ;
Deng, Manxiang ;
Chen, Luling .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (03) :1681-1686
[9]   Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease [J].
Castera, Laurent ;
Friedrich-Rust, Mireen ;
Loomba, Rohit .
GASTROENTEROLOGY, 2019, 156 (05) :1264-+
[10]   Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough [J].
Castera, Laurent .
LIVER INTERNATIONAL, 2018, 38 :67-70